Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.


Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Prostate Cancer News

This page features general updates about prostate cancer, research and studies, hot topics, news articles and editorials. You also might be interested in ZERO’s Blog, which features inspiring stories, commentary, and insight into news and current events from contributors throughout the prostate cancer community.

Mike Rowe Offers Live Commentary on His Own Prostate Exam in This Eye-Op...

AdWeek /
To show men just how easy it is to advocate for their own prostate health, ad agency Erich & Kallman worked with non-profit organization Zero – The End of Prostate Cancer to created a two-minute ...

Dementia Not Linked to ADT for Prostate Cancer

New research may ease concerns that androgen deprivation therapy (ADT) contributes to dementia in patients with prostate cancer (PCa). Read more ...

Baseline PSA levels measured at midlife predict risk of aggressive prost...

Black men are more likely to be diagnosed with, and to die from, prostate cancer yet recommendations about prostate cancer screening are primarily based on studies of white men. A new study led by investigators ...

‘Fry and Turnbull’ prostate cancer effect

Hospitals are seeing and treating more men with prostate cancer, partly thanks to celebrities raising awareness of the disease by speaking out about their own experiences, says the head of the NHS. Read more ...

Dr. Sharma Discusses Immunotherapy in Prostate Cancer

Padmanee Sharma, MD, PhD, professor of Immunology in the Department of Genitourinary Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses immunotherapy in prostate cancer. Learn more ...

Aggressive prostate and lung cancers are driven by common mechanisms, re...

Researchers have discovered a common process in the development of late-stage, small cell cancers of the prostate and lung. These shared molecular mechanisms could lead to the development of drugs to treat not just prostate ...

Conquering cancer by attacking the disease’s genetic abnormalities

Comprehensive tumor profiling — in which individuals are matched with drugs that target specific genetic mutations or other abnormalities — is becoming a cornerstone of cancer treatment. Learn more ...

August 2016

July 2016

June 2016